Zerbini G, Mangili R, Luzi L (1999) Higher post-absorptive C-peptide levels in type 1 diabetic patients without renal complications. Diabet Med 16:1048-1049Herbini G, Mangili R, Luzi L (1999) Higher post-absorp- tive C-peptide levels in type 1 diabetic patients without re- nal ...
mortality remains greatly increased compared to the general population. As this is largely the result of cardiovascular and renal complications, we aimed to review recent findings surrounding these diseases in type 1 diabetes.
ATTEMPT: Dapagliflozin Improves Renal Function, Glycemic Control in Children with Type 1 Diabetes ByAbigail Brooks, MA June 25th 2024 Findings highlight the potential utility of low-dose SGLT2 inhibitors for optimizing diabetes control and managing renal complications in pediatric patients with type 1 ...
conventional treatment groups, respectively.The model incorporates diabetic complications risk data from a type 1 diabetes population and synthesizes other type 1-specific data to estimate long-term outcomes of CVD, end-stage renal disease, LEA and risk of blindness, along with life expectancy and ...
- 《Diabetes》 被引量: 42发表: 2009年 Adult Stature and Diabetes Complications in Patients With Type 1 Diabetes. OBJECTIVE--Short adult stature has previously been associated with cardiovascular disease, but its relationship with the microvascular complications of dia... Wadén,Johan,Forsblom,......
Currently, the differentiation between type 1 diabetes (T1D) and type 2 diabetes (T2D) is not straightforward, and the features of both types of diabetes coexist in one subject. This situation triggered the need to discriminate so-called double diabetes
Type 1 diabetes is a chronic illness characterized by the body’s inability to produce insulin due to the autoimmune destruction of the beta cells in the pancreas. Onset most often occurs in childhood, but the disease can also develop in adults in their
Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidem... Microalbuminuria is a common diagnosis in the clinical care of patients with type 1 diabetes mellitus. Long-term outcomes after the development...
There is, however, a lack of evidence that relaxin treatment is effective in reversing a broader range of diabetes-induced cardiovascular complications, particularly in a model of Type 1 diabetes. Therefore, in the pres- ent study, we tested the hypothesis that in vivo recombinant human relaxin-...
There is much evidence that diabetes mellitus (DM)-induced hyperglycemia (HG) is responsible for kidney failure or nephropathy leading to cardiovascular complications. Cellular and molecular mechanism(s) whereby DM can damage the kidney is still not fully understood. This study investigated the effect...